We are Pandeia Therapeutics

Working towards novel therapeutics to treat motor symptoms associated with Huntington’s disease.

Who we are

Novel therapeutics to treat motor symptoms of Huntington’s disease.

Pandeia Therapeutics is an asset centric, VC funded biotech based in Oxford, UK. Our efforts are directed towards discovering and developing novel therapeutics to treat the motor symptoms associated with Huntington’s disease.

What We Do

Discovering and developing novel therapeutics to treat the motor symptoms associated with Huntington’s disease

About Us

Find out more about the team behind Pandeia Therapeutics.

The Science

Our approach to therapies for Huntington’s disease.

Latest News

All the latest company news, updates and press releases.

Contact Us

Get in touch with us to find more about what we do.

To find out more about Pandeia Therapeutics please get in touch.